Grifols plans to release Phase III results of ... in pursuit of approval. “We are working with different partners. In the immunology, and pulmonary disease space, to support their growth ...

U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical company Grifols .

No agreement has been reached with any of the funds, they said. Brookfield and the Grifols family, who are working together to potentially take the company private, have yet to present a formal ...

Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based biomarkers that could indicate a person’s likelihood of developing Parkinson’s ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Grifols’ repository of PD plasma samples is ... Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their ...

1 It occurs when brain cells that make dopamine, a chemical that coordinates movement, stop working or die. Despite decades of research ... early-warning system for the emergence of the disease.

BARCELONA, Spain, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Grifols (MCE: GRF ... a chemical that coordinates movement, stop working or die. Despite decades of research and treatment advancement, the ...